Mates Sharon bought BNTC
December 1, 2025 · Form 4 insider transaction
Mates Sharon bought 3,500 shares of Benitec Biopharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,500
Price
$0.00
Total value
N/A
InsiderMates Sharon
RoleDirector
SecurityOptions (right to buy)
Transaction codeA: Grant or award
Transaction dateDecember 1, 2025
Filing dateDecember 3, 2025
Shares owned after3,500
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 1, 2026.